167 related articles for article (PubMed ID: 26522953)
21. BM6, a new semi-synthetic vinca alkaloid, exhibits its potent in vivo anti-tumor activities via its high binding affinity for tubulin and improved pharmacokinetic profiles.
Li W; Shao Y; Hu L; Zhang X; Chen Y; Tong L; Li C; Shen X; Ding J
Cancer Biol Ther; 2007 May; 6(5):787-94. PubMed ID: 17387272
[TBL] [Abstract][Full Text] [Related]
22. Vinflunine.
Shnyder SD
IDrugs; 2004 Sep; 7(9):851-9. PubMed ID: 15470603
[TBL] [Abstract][Full Text] [Related]
23. Elaboration of thorough simplified vinca alkaloids as antimitotic agents based on pharmacophore similarity.
Zheng J; Deng L; Chen M; Xiao X; Xiao S; Guo C; Xiao G; Bai L; Ye W; Zhang D; Chen H
Eur J Med Chem; 2013 Jul; 65():158-67. PubMed ID: 23708010
[TBL] [Abstract][Full Text] [Related]
24. Modifications in the "upper" velbenamine part of the Vinca alkaloids have major implications for tubulin interacting activities.
Fahy J
Curr Pharm Des; 2001 Sep; 7(13):1181-97. PubMed ID: 11472261
[TBL] [Abstract][Full Text] [Related]
25. QM and QM/MD simulations of the Vinca alkaloids docked to tubulin.
Kelly EB; Tuszynski JA; Klobukowski M
J Mol Graph Model; 2011 Sep; 30():54-66. PubMed ID: 21798777
[TBL] [Abstract][Full Text] [Related]
26. One-pot synthesis of vinca alkaloids-phomopsin hybrids.
Gherbovet O; Coderch C; García Alvarez MC; Bignon J; Thoret S; Guéritte F; Gago F; Roussi F
J Med Chem; 2014 Jun; 57(12):5470-6. PubMed ID: 24871162
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological evaluation of antitumour-active betulin derivatives.
Csuk R; Barthel A; Kluge R; Ströhl D; Kommera H; Paschke R
Bioorg Med Chem; 2010 Feb; 18(3):1344-55. PubMed ID: 20034802
[TBL] [Abstract][Full Text] [Related]
28. Plant products in cancer chemotherapy.
Carter SK; Livingston RB
Cancer Treat Rep; 1976 Aug; 60(8):1141-56. PubMed ID: 791484
[No Abstract] [Full Text] [Related]
29. Molecular docking and pharmacogenomics of vinca alkaloids and their monomeric precursors, vindoline and catharanthine.
Sertel S; Fu Y; Zu Y; Rebacz B; Konkimalla B; Plinkert PK; Krämer A; Gertsch J; Efferth T
Biochem Pharmacol; 2011 Mar; 81(6):723-35. PubMed ID: 21219884
[TBL] [Abstract][Full Text] [Related]
30. Tubulin-based structure-affinity relationships for antimitotic Vinca alkaloids.
Coderch C; Morreale A; Gago F
Anticancer Agents Med Chem; 2012 Mar; 12(3):219-25. PubMed ID: 22044006
[TBL] [Abstract][Full Text] [Related]
31. New vinca alkaloids and related compounds.
Budman DR
Semin Oncol; 1992 Dec; 19(6):639-45. PubMed ID: 1462165
[TBL] [Abstract][Full Text] [Related]
32. Total synthesis and biological evaluation of jerantinine E.
Frei R; Staedler D; Raja A; Franke R; Sasse F; Gerber-Lemaire S; Waser J
Angew Chem Int Ed Engl; 2013 Dec; 52(50):13373-6. PubMed ID: 24127420
[No Abstract] [Full Text] [Related]
33. Plasma pharmacokinetics of vinblastine and the investigational Vinca alkaloid N-(deacetyl-O-4-vinblastoyl-23)-L-ethyl isoleucinate in mice as determined by high-performance liquid chromatography.
van Tellingen O; Beijnen JH; Nooijen WJ; Bult A
Cancer Res; 1993 May; 53(9):2061-5. PubMed ID: 8481908
[TBL] [Abstract][Full Text] [Related]
34. The syntheses of 16a'-homo-leurosidine and 16a'-homo-vinblastine. Generation of atropisomers.
Kuehne ME; Qin Y; Huot AE; Bane SL
J Org Chem; 2001 Aug; 66(16):5317-28. PubMed ID: 11485450
[TBL] [Abstract][Full Text] [Related]
35. Alkaloids of Vinca rosea L. (Catharanthus roseus G. Don). 38. 4'-Dehydrated derivatives.
Miller JC; Gutowski GE; Poore GA; Boder GB
J Med Chem; 1977 Mar; 20(3):409-13. PubMed ID: 576619
[TBL] [Abstract][Full Text] [Related]
36. Riboflavin-mediated photosensitization of Vinca alkaloids distorts drug sensitivity assays.
Granzow C; Kopun M; Kröber T
Cancer Res; 1995 Nov; 55(21):4837-43. PubMed ID: 7585517
[TBL] [Abstract][Full Text] [Related]
37. [Alkaloids of Vinca rosea L. introduced to Western Georgia].
Vachnadze NS; Kintsurashvili LG; Suladze TSh; Bakuridze AD; Vachnadze VIu
Georgian Med News; 2013 Nov; (224):85-8. PubMed ID: 24323972
[TBL] [Abstract][Full Text] [Related]
38. Cytotoxicity, cell cycle kinetics and morphonuclear-induced effects of Vinca alkaloid anticancer agents.
Pauwels O; Kiss R; Pasteels JL; Atassi G
J Pharm Pharmacol; 1995 Oct; 47(10):870-5. PubMed ID: 8583358
[TBL] [Abstract][Full Text] [Related]
39. Three new monoterpenoid indole alkaloids from Vinca major.
Zhang ZJ; Du RN; He J; Wu XD; Li Y; Li RT; Zhao QS
J Asian Nat Prod Res; 2016; 18(4):328-33. PubMed ID: 26700398
[TBL] [Abstract][Full Text] [Related]
40. A new type of monoterpenoid indole alkaloid precursor from Alstonia rostrata.
Cai XH; Bao MF; Zhang Y; Zeng CX; Liu YP; Luo XD
Org Lett; 2011 Jul; 13(14):3568-71. PubMed ID: 21688858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
